Cardiovascular technology developer Cordis today announced the appointment of Dr George Adams as the new Chief Medical Officer.
Cordis, based in Miami Lakes, Fla., Said in a press release that the hiring of Adams strengthens its mission to differentiate itself as a technology leader and global value-based medical device company.
“We are delighted that Dr Adams is joining our team as we continue to build the new Cordis,” said the CEO of Corids. Shar Morning noted in the exit. “His extensive expertise in the treatment of complex coronary heart and peripheral vascular disease will play a critical role in continuing our mission to improve patient care at the pace of cost-effective, differentiated solutions that build on our heritage of innovation. “
Adams joins Corids with a combination of clinical practice, medical research and product development experience, the company said. He has expertise in the treatment of peripheral vascular disease in patients with critical limb ischemia (MCI) and coronary artery disease and is involved in the development of regional and national systems of care for the treatment of MCI, Myocardial infarction with ST segment elevation and management of coronary heart disease and peripheral vascular disease.
He was also the principal investigator of several clinical trials and is certified by the American Board of Internal Medicine in internal medicine and cardiovascular disease.
“It is with great honor and enthusiasm that I join the Cordis team as Chief Medical Officer,” Adams said. “I look forward to playing a role in revitalizing an incredible 62-year legacy. I am grateful to be a part of the future Cordis is building with integrity and a vision for innovation.
Interactions with readers